Developing Topics.

Alzheimers Dement

University of Bristol, Bristol, Horfield, United Kingdom.

Published: December 2024

Background: Cerebral hypoperfusion and blood-brain barrier (BBB) leakiness within the precuneus is common in early-stage Alzheimer's disease (AD). Pericyte-derived angiopoietin-1 (ANGPT-1) activates endothelial TIE-2 receptors promoting vascular stability whereas endothelial cell-derived ANGPT-2, a weak agonist or antagonist of TIE-2, promotes BBB leakiness. Endothelial TIE-1 also regulates TIE-2 signalling. We recently showed elevated ANGPT2 level in mild-cognitive impairment related to albumin, a marker of BBB leakiness, in CSF. In this study, we examined ANGPT/TIE signalling in brain tissue and microvessel-enriched fractions (MVFs) in relation to AD progression and cerebrovascular injury.

Method: We studied parietal cortex (Brodmann area 7) from Braak tangle stage (BS) 0-II (n = 17), III-IV (n = 23) and V-VI (n = 22) from cases obtained from the South-West Dementia Brain Bank, University of Bristol. ANGPT-1, ANGPT-2, TIE-1, and TIE-2 levels in brain tissue and MVFs were measured by ELISA. CD31 level was used to adjust for endothelial content. MAG and PLP1 levels, to assess brain oxygenation and fibrinogen, to assess BBB integrity, were measured by ELISA. One-way ANOVA with Tukey's post hoc testing was used to compare groups and Pearson's correlation coefficient was used to assess relationships between ANGPT/TIE, MAG:PLP and fibrinogen.

Result: In crude homogenates, ANGPT-1 level was elevated in BSV-VI compared to BS0-II (p = 0.06) and BSIII-IV (p = 0.0005). TIE-2 was reduced in BSIII-IV compared to BS0-II (p = 0.004) and BSV-VI (p = 0.001) in crude homogenates and was lower in MVFs in BSV-VI than BS0-II (p = 0.02). ANGPT-2 level was higher in BSV-VI than BSIII-IV in brain tissue (p = 0.04). However, both ANGPT-2 and TIE-1 levels were unaltered in relation to BS in MVFs. Across the entire cohort, ANGPT-2 level correlated inversely with MAG:PLP1 ratio in BSIII-IV (p = 0.052, r = -0.42) but positively with MAG:PLP1 (p = 0.04, r = 0.46) and fibrinogen level (p = 0.02, r = 0.49) in BSV-VI brains.

Conclusion: The expression of the stabilising receptor, TIE-2, was reduced in early-stage AD and ANGPT2 expression was differentially related to perfusion and BBB leakiness dependent on disease stage. The study highlights important differences in ANGPT/TIE signalling in relation to disease stage and illustrates a complex relationship between brain, microvascular, and CSF changes that warrants further investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/alz.095139DOI Listing

Publication Analysis

Top Keywords

bbb leakiness
16
brain tissue
12
angpt/tie signalling
8
angpt-2 tie-1
8
measured elisa
8
crude homogenates
8
compared bs0-ii
8
tie-2 reduced
8
angpt-2 level
8
disease stage
8

Similar Publications

Systemically administered platelet-inspired nanoparticles to reduce inflammation surrounding intracortical microelectrodes.

Biomaterials

January 2025

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, United States; Advanced Platform Technology Center, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH, United States. Electronic address:

Intracortical microelectrodes (IMEs) are essential for neural signal acquisition in neuroscience and brain-machine interface (BMI) systems, aiding patients with neurological disorders, paralysis, and amputations. However, IMEs often fail to maintain robust signal quality over time, partly due to neuroinflammation caused by vascular damage during insertion. Platelet-inspired nanoparticles (PIN), which possess injury-targeting functions, mimic the adhesion and aggregation of active platelets through conjugated collagen-binding peptides (CBP), von Willebrand Factor-binding peptides (VBP), and fibrinogen-mimetic peptides (FMP).

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

cheonan chungmu hospital, cheonan si, Korea, Republic of (South).

Background: Vascular contributions to dementia & Alzheimer's disease are increasing recognized. Recent studies have suggested that blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction, including the early clinical stages of AD. Apolipoprotein E4(APOE4), the major AD susceptibility gene, leads to accelerated blood-brain barrier breakdown & degeneration of brain capillary pericyte that maintain blood-brain barrier integrity.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

University of Bristol, Bristol, Horfield, United Kingdom.

Background: Cerebral hypoperfusion and blood-brain barrier (BBB) leakiness within the precuneus is common in early-stage Alzheimer's disease (AD). Pericyte-derived angiopoietin-1 (ANGPT-1) activates endothelial TIE-2 receptors promoting vascular stability whereas endothelial cell-derived ANGPT-2, a weak agonist or antagonist of TIE-2, promotes BBB leakiness. Endothelial TIE-1 also regulates TIE-2 signalling.

View Article and Find Full Text PDF

Regulation of the blood-brain barrier function by peripheral cues in health and disease.

Metab Brain Dis

December 2024

Institute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.

The blood-brain barrier (BBB) is formed by microvascular endothelial cells which are ensembled with pericytes, astrocytes, microglia and neurons in the neurovascular unit (NVU) that is crucial for neuronal function. Given that the NVU and the BBB are highly dynamic and regulated structures, their integrity is continuously challenged by intrinsic and extrinsic factors. Herein, factors from peripheral organs such as gonadal and adrenal hormones may influence vascular function also in CNS endothelial cells in a sex- and age-dependent manner.

View Article and Find Full Text PDF

Aging disrupts blood-brain and blood-spinal cord barrier homeostasis, but does not increase paracellular permeability.

Geroscience

October 2024

Neurobiology of Aging and Dementia Laboratory, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.

Article Synopsis
  • Blood-CNS barriers help protect the central nervous system (CNS) by blocking immune cells and harmful molecules, but their integrity may decline with age, impacting CNS function.
  • Research showed that aging primarily affects genes linked to immune responses and pericyte function in certain CNS regions, particularly the spinal cord, but does not significantly alter endothelial cell junctions or vascular structures.
  • The study found no evidence of increased paracellular permeability in blood-brain and blood-spinal cord barriers with normal aging in mice, suggesting that while gene expression changes occur, they do not directly lead to permeability issues unless there are additional stressors.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!